Managers / Q3 2025 · view latest →
HALL CAPITAL MANAGEMENT CO INC
CIK 0001122490 · 26 BOSWORTH STREET, SUITE 4, BARRINGTON, RI, 02806 · 4012450049
Summary
Hall Capital Management Co Inc reported $254M in U.S.-listed holdings across 98 positions for Q3 2025.
Its largest position, MSFT, represents 7.6% of the portfolio.
Compared with Q2 2025, the fund opened 4 new positions and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 61.9% · $157M
- ETP · 36.6% · $93M
- REIT · 1.2% · $3M
- Other · 0.2% · $410,770
- ADR · 0.1% · $251,350
Quarter-over-Quarter Changes full breakdown →
vs Q2 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SELECT SECTOR SPDR TR | NEW | +903 | 903 | +$216,395 | $216,395 |
| DWDMORGAN STANLEY | NEW | +1.3K | 1.3K | +$210,781 | $210,781 |
| PLTRPALANTIR TECHNOLOGIES INC | NEW | +1.1K | 1.1K | +$209,236 | $209,236 |
| VANGUARD INDEX FDS | NEW | +625 | 625 | +$205,106 | $205,106 |
| BSXBOSTON SCIENTIFIC CORP | ADDED | +15.4K | 20.6K | +$1M | $2M |
| TMOTHERMO FISHER SCIENTIFIC INC | TRIMMED | −3.3K | 1.6K | −$1M | $772,152 |
| MRKMERCK & CO INC | TRIMMED | −1.4K | 3.7K | −$96,566 | $306,596 |
| NVSNNOVARTIS AG | TRIMMED | −395 | 2.0K | −$33,629 | $251,350 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $280M | 107 | May 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $259M | 98 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $254M | 98 | Nov 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $237M | 94 | Jul 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $216M | 92 | May 8, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $214M | 101 | Feb 24, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $210M | 98 | Jul 26, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $203M | 98 | May 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $170M | 93 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $156M | 91 | Oct 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $177M | 92 | Aug 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $169M | 93 | Apr 18, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $166M | 91 | Feb 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $150M | 90 | Oct 19, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $152M | 90 | Jul 19, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $171M | 98 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $157M | 93 | Oct 8, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $155M | 95 | Jul 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $138M | 85 | Mar 2, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $119M | 79 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $98M | 74 | Apr 29, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $123M | 82 | Feb 4, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $115M | 81 | Oct 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $117M | 83 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $115M | 84 | May 6, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $101M | 77 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.